Amanote Research
Register
Sign In
Cost-Effectiveness of New Oral Anticoagulants for Patients With Atrial Fibrillation – A Decision Analysis
Value in Health
- United Kingdom
doi 10.1016/j.jval.2013.03.1482
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
May 1, 2013
Authors
J. You
Publisher
Elsevier BV
Related search
Cost-Effectiveness of Oral Anticoagulants for Treatment of Atrial Fibrillation
Circulation. Cardiovascular quality and outcomes
Medicine
Cardiovascular Medicine
Cardiology
Clinical Outcomes and Cost-Effectiveness of Novel Oral Anticoagulants Incorporating Real-World Elderly Patients With Atrial Fibrillation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of New Oral Anticoagulants Compared With Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients With Atrial Fibrillation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Oral Anticoagulants for Prevention of Stroke in Atrial Fibrillation: Systematic Review, Network Meta-Analysis, and Cost Effectiveness Analysis
British Medical Journal
Medicine
Satisfaction With Oral Anticoagulants in Patients With Atrial Fibrillation
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
New Anticoagulants for Atrial Fibrillation
Seminars in Thrombosis and Hemostasis
Cardiovascular Medicine
Hematology
Cardiology
Periprocedural Management of New Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Cost-Effectiveness of Therapies for Patients With Nonvalvular Atrial Fibrillation
Archives of Internal Medicine
Underuse of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation in Italy
Internal and Emergency Medicine
Internal Medicine
Emergency Medicine
